治疗性疫苗的研究进展附视频

被引:19
作者
闻玉梅
机构
[1] 上海医科大学卫部医学分子病毒学重点实验室!
关键词
疫苗; 应用研究; 微生物学; 乙肝患者; 菌苗; 科学研究; 治疗性; 复合物;
D O I
暂无
中图分类号
R186 [预防接种、计划免疫、药物预防];
学科分类号
100401 ;
摘要
由微生物传染的慢性病大多是较难治疗的疾病,尤其文谱耐药的细菌性和某些病毒性疾患。例如:慢性结核病、乙型肝炎、艾滋病等都是很难治愈的疾病,目前尚无有产对策。疫苗作为免疫制品主要用于预防传染性疾病,而对其治疗用途的探索较少。虽然如此,国内外合肥市有一些研究报告,如泌司法部系统慢性细菌感染、疱疹性角膜溃疡、乙型肝炎等。采用疫苗治疗,并取得一定的疗效。卡介苗用于膀胱癌辅助治疗的效果,可认为是非特异作用所致,但大多治疗用疫苗的作用机理未能进一步研究。本刊与卫生部医学分子病毒学重点实验室上海联合召开的学术报告会上,闻玉梅教授总结分析了国内外文献和自己的研究结果,提出治疗性疫苗的开发是综合微生物学与免疫学理论及应用研究的一个新领域。此文具有学术新颖性和创造性,值得微生物学和免疫学界的研究工作者特别是从事生物制品研究的人员一读和参考。
引用
收藏
页码:155 / 158
页数:4
相关论文
共 9 条
[1]  
Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice :A possible way of circumventing " nonresponse" to HBsAg. Mancini M,Hadchouel M,Tiollais P,et al. Journal of Medical Virology . 1993
[2]  
Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy. Wen YM,Wu ZH,Hu DC,et al. The Lancet . 1995
[3]  
Placebo-controlled trial of vaccination with recombinant glycopratein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Straus SE,Corey L,Burke RL,et al. The Lancet . 1994
[4]  
Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Zaghouani H,Anderson S,Sperber KE,et al. Proceedings of the National Academy of Sciences of the United States of America . 1995
[5]  
Vaccines get a new twist. Cohen J. Science . 1994
[6]  
Specific vaccine therapy in chronic hepatitis B infection. Pol S,Driss F,Michel M-L,Nalpas B,et al. The Lancet . 1994
[7]  
Solid matrix-antibody-antigen complex can clear viraemia and antigenaemia in persistent duck hepatitis B virus infection. Wen YM,Xiong SD,Zhang W. Journal of General Virology . 1994
[8]  
Vaccine therapy for HIV , A historical review of the treatment of infectious diseases by active specific immunization with mocrobe-derived antigens. Burke DS. Vaccine . 1993
[9]  
DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Davis HL,Michel M-L,Whalen RG. Human Molecular Genetics . 1993